Morphine Sulfate Extended Release (Page 10 of 10)

Package/Label Display Panel – Carton – 30 mg

30 mg Morphine Sulfate Extended-Release Tablets Carton
(click image for full-size original)

NDC 68084- 158 -01

Morphine Sulfate     CII
Extended-Release Tablets

30 mg

100 Tablets (10 x 10)               Rx Only

PHARMACIST: Dispense with the accompanying Medication
Guide to each patient.

Each Tablet Contains:
Morphine Sulfate USP………………………………………………….30 mg

Usual Dosage: See package insert for full prescribing
information.
Swallow tablets whole. Do not break, crush, dissolve, or
chew.

Store at 20° to 25°C (68° to 77°F); excursions permitted
between 15° to 30°C (59° to 86°F) [see USP Controlled Room
Temperature].

DEA Order Form Required

Keep this and all drugs out of reach of children.

FOR YOUR PROTECTION: Do not use if blister is torn or
broken.

The drug product contained in this package is from
NDC # 42858-802, Rhodes Pharmaceuticals L. P.

Packaged and Distributed by:
American Health Packaging
Columbus, Ohio 43217

015801 0215801/0419

Package/Label Display Panel – Blister – 30 mg

30 mg Morphine Sulfate Extended-Release Tablet Blister
(click image for full-size original)

Morphine Sulfate
Extended-Release      CII Tablet           30 mg

MORPHINE SULFATE EXTENDED RELEASE morphine sulfate tablet, film coated, extended release
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:68084-157(NDC:42858-801)
Route of Administration ORAL DEA Schedule CII
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
MORPHINE SULFATE (MORPHINE) MORPHINE SULFATE 15 mg
Inactive Ingredients
Ingredient Name Strength
CETOSTEARYL ALCOHOL
HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%)
HYPROMELLOSE, UNSPECIFIED
MAGNESIUM STEARATE
POLYETHYLENE GLYCOL, UNSPECIFIED
TALC
TITANIUM DIOXIDE
FD&C BLUE NO. 2
LACTOSE MONOHYDRATE
POLYSORBATE 80
Product Characteristics
Color blue Score no score
Shape ROUND Size 7mm
Flavor Imprint Code ABG;15
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:68084-157-01 100 BLISTER PACK in 1 BOX, UNIT-DOSE contains a BLISTER PACK (68084-157-11)
1 NDC:68084-157-11 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK This package is contained within the BOX, UNIT-DOSE (68084-157-01)
Image of Product
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA074862 10/21/2013
MORPHINE SULFATE EXTENDED RELEASE morphine sulfate tablet, film coated, extended release
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:68084-158(NDC:42858-802)
Route of Administration ORAL DEA Schedule CII
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
MORPHINE SULFATE (MORPHINE) MORPHINE SULFATE 30 mg
Inactive Ingredients
Ingredient Name Strength
CETOSTEARYL ALCOHOL
HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%)
HYPROMELLOSE, UNSPECIFIED
MAGNESIUM STEARATE
POLYETHYLENE GLYCOL, UNSPECIFIED
TALC
TITANIUM DIOXIDE
D&C RED NO. 7
FD&C BLUE NO. 1
LACTOSE MONOHYDRATE
POLYSORBATE 80
Product Characteristics
Color purple (Lavender) Score no score
Shape ROUND Size 7mm
Flavor Imprint Code ABG;30
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:68084-158-01 100 BLISTER PACK in 1 BOX, UNIT-DOSE contains a BLISTER PACK (68084-158-11)
1 NDC:68084-158-11 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK This package is contained within the BOX, UNIT-DOSE (68084-158-01)
Image of Product
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA074862 08/27/2013
Labeler — American Health Packaging (929561009)
Establishment
Name Address ID/FEI Operations
American Health Packaging 929561009 repack (68084-157), repack (68084-158)

Revised: 08/2022 American Health Packaging

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2022. All Rights Reserved.